Drugs that contain Trifarotene

1. Drug name - AKLIEF

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7807708 GALDERMA LABS LP Ligands that modulate RAR receptors and pharmaceutical/cosmetic compositions comprised thereof
Oct, 2026

(3 years from now)

CN101087752B GALDERMA LABS LP New Ligand Of Adjusting Rar Receptor And Use Thereof In Human Medicine And Cosmetics
Dec, 2025

(3 years from now)

CN101087752A GALDERMA LABS LP New Ligand Of Adjusting Rar Receptor And The Usage In The Human Medicine And Makeup Thereof
Dec, 2025

(3 years from now)

IN200705201P1 GALDERMA LABS LP Novel Ligands That Modulate Rar Receptors And Use Thereof Inhuman Medicine And In Cosmetics
Dec, 2025

(3 years from now)

IN284413B GALDERMA LABS LP Novel Ligands That Modulate Rar Receptors And Use Thereof In Human Medicine And In Cosmetics
Dec, 2025

(3 years from now)

EP1831149B1 GALDERMA LABS LP Novel Ligands That Modulate Rar Receptors And Use Thereof In Human Medicine And In Cosmetics
Dec, 2025

(3 years from now)

EP1831149A1 GALDERMA LABS LP Novel Ligands That Modulate Rar Receptors And Use Thereof In Human Medicine And In Cosmetics
Dec, 2025

(3 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8470871 GALDERMA LABS LP Ligands that modulate RAR receptors Dec, 2025

(3 years from now)

US8227507 GALDERMA LABS LP Ligands that modulate RAR receptors Dec, 2025

(3 years from now)

US9084778 GALDERMA LABS LP Topical compositions containing a retinoid of the oil-in-water emulsion type May, 2033

(10 years from now)

US9498465 GALDERMA LABS LP Topical compositions in the form of a gel containing a particular solubilized retinoid May, 2033

(10 years from now)

Treatment: Method of activating rargamma receptor; Topical treatment of acne vulgaris; Treatment of acne vulgaris

Dosage: CREAM;TOPICAL

More Information on Dosage
Strength Dosage Availability
0.005% CREAM;TOPICAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.